FDA
-
-
-
-
-
-
-
Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes
-
-
-
-
-
-
-
Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor
-
-
-
-
-
-
-
Senseonics Holdings (SENS) Issues FY24 Guidance
-
-
-
-
-
-
-
Senseonics Holdings (SENS) Provides Business Update
-
-
-
-
-
-
-
Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System
-
-
-
-
-
-
-
Senseonics Holdings (SENS) Announces FDA Approval of the Eversense E3 Continuous Glucose Monitoring System
-
-
-
-
-
-
-
Senseonics Holdings (SENS) Announces Results of the PROMISE Study Demonstrating Strong Accuracy of 180 Day CGM Sensor
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

